MaxCyte, Inc. (MXCT)

MaxCyte Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	38.63	41.29	44.26	33.89	26.17
Revenue Growth (YoY)	-6.44%	-6.72%	30.59%	29.52%	21.04%
Cost of Revenue	7.1	4.74	5.1	3.65	2.77
Gross Profit	31.53	36.55	39.16	30.25	23.4
Selling, General & Admin	56.35	57.04	44.48	31.68	15.7
Research & Development	22.23	23.82	19.51	15.41	17.73
Operating Expenses	82.72	84.85	66.52	48.44	34.46
Operating Income	-51.2	-48.3	-27.36	-18.19	-11.06
Interest Expense	-	-	-	-0.4	-0.46
Interest & Investment Income	10.14	10.38	3.92	0.15	0.07
Other Non Operating Income (Expenses)	-	-	-0.13	-0.65	-0.37
Pretax Income	-41.06	-37.92	-23.57	-19.08	-11.82
Net Income	-41.06	-37.92	-23.57	-19.08	-11.82
Net Income to Common	-41.06	-37.92	-23.57	-19.08	-11.82
Shares Outstanding (Basic)	105	103	102	91	69
Shares Outstanding (Diluted)	105	103	102	91	69
Shares Change (YoY)	1.53%	1.54%	12.23%	30.45%	23.17%
EPS (Basic)	-0.39	-0.37	-0.23	-0.21	-0.17
EPS (Diluted)	-0.39	-0.37	-0.23	-0.21	-0.17
Free Cash Flow	-29.26	-25.39	-33.26	-14.51	-10.85
Free Cash Flow Per Share	-0.28	-0.25	-0.33	-0.16	-0.16
Gross Margin	81.62%	88.51%	88.48%	89.24%	89.43%
Operating Margin	-132.54%	-116.98%	-61.82%	-53.66%	-42.25%
Profit Margin	-106.29%	-91.85%	-53.25%	-56.30%	-45.15%
Free Cash Flow Margin	-75.75%	-61.49%	-75.15%	-42.82%	-41.48%
EBITDA	-46.88	-44.13	-24.66	-16.76	-10.01
EBITDA Margin	-121.37%	-106.88%	-55.72%	-49.46%	-38.25%
D&A For EBITDA	4.32	4.17	2.7	1.42	1.05
EBIT	-51.2	-48.3	-27.36	-18.19	-11.06
EBIT Margin	-132.54%	-116.98%	-61.82%	-53.66%	-42.25%

Source: S&P Capital IQ. Standard template. Financial Sources.